Renoprotective Effect of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus

• Principais autores: Hiroki Esaki (Autor), Tomoya Tachi (Autor), Chitoshi Goto (Autor), Ikuto Sugita (Autor), Yuta Kanematsu (Autor), Aki Yoshida (Autor), Kosuke Saito (Autor), Yoshihiro Noguchi (Autor), Yuki Ohno (Autor), Satoshi Aoyama (Autor), Masahiro Yasuda (Autor), Takashi Mizui (Autor), Masumi Yamamura (Autor), Hitomi Teramachi (Autor)
• Formato: Livro
• Publicado em: Frontiers Media S.A., 2017-11-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Diabetic nephropathy is one of three major complications of diabetes mellitus, often leading to chronic renal failure requiring dialysis. Recently developed dipeptidyl peptidase-4 (DPP-4) inhibitors may exhibit renoprotective effects in addition to antihyperglycemic effects. In this study, we retros...